BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 19127431)

  • 1. Impact of the patient-provider relationship on the survival of foreign born outpatients with tuberculosis.
    Gardam M; Verma G; Campbell A; Wang J; Khan K
    J Immigr Minor Health; 2009 Dec; 11(6):437-45. PubMed ID: 19127431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival Analysis of Risk Factors for Mortality in a Cohort of Patients with Tuberculosis.
    Xie Y; Han J; Yu W; Wu J; Li X; Chen H
    Can Respir J; 2020; 2020():1654653. PubMed ID: 32963642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of physician training and experience on the survival of patients with active tuberculosis.
    Khan K; Campbell A; Wallington T; Gardam M
    CMAJ; 2006 Sep; 175(7):749-53. PubMed ID: 17001055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors and mortality associated with treatment default in pulmonary tuberculosis.
    Kliiman K; Altraja A
    Int J Tuberc Lung Dis; 2010 Apr; 14(4):454-63. PubMed ID: 20202304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of comorbidity on mortality following in-hospital diagnosis of tuberculosis.
    Rao VK; Iademarco EP; Fraser VJ; Kollef MH
    Chest; 1998 Nov; 114(5):1244-52. PubMed ID: 9823996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mortality of tuberculosis patients during treatment in Israel, 2000-2010.
    Shuldiner J; Leventhal A; Chemtob D; Mor Z
    Int J Tuberc Lung Dis; 2014 Jul; 18(7):818-23. PubMed ID: 24902558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of country of origin on drug-resistant tuberculosis among foreign-born persons in British Columbia.
    Moniruzzaman A; Elwood RK; Schulzer M; FitzGerald JM
    Int J Tuberc Lung Dis; 2006 Aug; 10(8):844-50. PubMed ID: 16898367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Language Barriers Among the Foreign-Born in Canada: Agreement of Self-Reported Measures and Persistence Over Time.
    Okrainec K; Booth GL; Hollands S; Bell CM
    J Immigr Minor Health; 2017 Feb; 19(1):50-56. PubMed ID: 26395900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of DOTS compared with DOTS-plus on multidrug resistant tuberculosis and tuberculosis deaths: decision analysis.
    Sterling TR; Lehmann HP; Frieden TR
    BMJ; 2003 Mar; 326(7389):574. PubMed ID: 12637401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multidrug-resistant tuberculosis in Lisbon: unfavourable treatment and associated factors, 2000-2014.
    Bhering M; Kritski A; Nunes C; Duarte R
    Int J Tuberc Lung Dis; 2019 Oct; 23(10):1075-1081. PubMed ID: 31627772
    [No Abstract]   [Full Text] [Related]  

  • 11. Factors associated with treatment outcomes in pulmonary tuberculosis in northeastern Thailand.
    Anunnatsiri S; Chetchotisakd P; Wanke C
    Southeast Asian J Trop Med Public Health; 2005 Mar; 36(2):324-30. PubMed ID: 15916037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isoniazid Mono-Resistant Tuberculosis: Impact on Treatment Outcome and Survival of Pulmonary Tuberculosis Patients in Southern Mexico 1995-2010.
    Báez-Saldaña R; Delgado-Sánchez G; García-García L; Cruz-Hervert LP; Montesinos-Castillo M; Ferreyra-Reyes L; Bobadilla-Del-Valle M; Canizales-Quintero S; Ferreira-Guerrero E; Téllez-Vázquez N; Montero-Campos R; Yanes-Lane M; Mongua-Rodriguez N; Martínez-Gamboa RA; Sifuentes-Osornio J; Ponce-de-León A
    PLoS One; 2016; 11(12):e0168955. PubMed ID: 28030600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Difficulties in the treatment of pulmonary tuberculosis in children].
    Brînză N; Mihăescu T
    Rev Med Chir Soc Med Nat Iasi; 2007; 111(4):852-5. PubMed ID: 18389769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Tuberculosis in Poland, Europe, and world. Part II--mortality, drug resistance and HIV infection].
    Zielonka TM
    Pol Merkur Lekarski; 2006 Sep; 21(123):253-61. PubMed ID: 17163187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival of people living with HIV who defaulted from tuberculosis treatment in a cohort, Recife, Brazil.
    Cunha R; Maruza M; Montarroyos UR; Coimbra I; de B Miranda-Filho D; Albuquerque MF; Lacerda HR; Ximenes R
    BMC Infect Dis; 2017 Feb; 17(1):137. PubMed ID: 28187753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors affecting the mortality of HIV-infected patients with pulmonary tuberculosis in the cART era: a retrospective cohort study in China.
    Ji YJ; Liang PP; Shen JY; Sun JJ; Yang JY; Chen J; Qi TK; Wang ZY; Song W; Tang Y; Liu L; Zhang RF; Shen YZ; Lu HZ
    Infect Dis Poverty; 2018 Mar; 7(1):25. PubMed ID: 29587840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nativity and Perceived Healthcare Quality.
    Orom H
    J Immigr Minor Health; 2016 Jun; 18(3):636-643. PubMed ID: 25957045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for unfavorable outcome of pulmonary tuberculosis in adults in Taipei, Taiwan.
    Yen YF; Yen MY; Shih HC; Deng CY
    Trans R Soc Trop Med Hyg; 2012 May; 106(5):303-8. PubMed ID: 22387265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trends and challenges in tuberculosis in a medium-sized southern European setting.
    Pasticci MB; Mazzolla R; Mercuri A; Gamboni G; Bombaci JC; Tiecco C; Rubeca M; Papili R; Pasticci F; Casali L; Ferrara G; Baldelli F
    Int J Tuberc Lung Dis; 2012 May; 16(5):645-8. PubMed ID: 22410587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of pulmonary tuberculosis on survival of HIV-infected adults: a prospective epidemiologic study in Uganda.
    Whalen CC; Nsubuga P; Okwera A; Johnson JL; Hom DL; Michael NL; Mugerwa RD; Ellner JJ
    AIDS; 2000 Jun; 14(9):1219-28. PubMed ID: 10894287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.